Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer.

Authors:
Liang Y; Zhang P; Li F; Lai H; Qi T and 1 more

Journal:
Front Pharmacol

Publication Year: 2024

DOI:
10.3389/fphar.2023.1332539

PMCID:
PMC10862125

PMID:
38352694

Journal Information

Full Title: Front Pharmacol

Abbreviation: Front Pharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Supported by Sichuan Science and Technology Program, NO: 2022YFGO194,2022YZD0092 Chengdu Science and Technology Bureau Technology Innovation R&D Project: 2022-YF05-01812-SN."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025